TABLE 4.
Kinetic parameters for substrates of VV TK and human TK1 using new experimental compounds
Substrate | VV TK
|
Human TK1
|
||||
---|---|---|---|---|---|---|
Km (μM)a | Vmax (μM min−1 mg−1)a | Vmax/Kmb | Km (μM)a | Vmax (μM min−1 mg−1)a | Vmax/Kmb | |
1 | 9.6 ± 5.5 | 120 ± 46 | 12 | 113 ± 20 | 130 ± 65 | 1.2 |
2 | 13 ± 5.2 | 119 ± 6 | 9 | 118 ± 14 | 98 ± 21 | 0.8 |
3 | 103 ± 2.9 | 91 ± 33.4 | 0.9 | >200 | <55 | <0.28 |
4 | 11 ± 7.9 | 106 ± 7 | 9.6 | >200 | <55 | <0.28 |
5 | 21 ± 1.1 | 91 ± 3 | 4.3 | >200 | <55 | <0.28 |
6 | 97 ± 26 | 78 ± 7 | 0.8 | >200 | <55 | <0.28 |
dThd | 21 ± 12 | 302 ± 7 | 15 | 23 ± 13 | 334 ± 192 | 14.5 |
CDV | >200 | <55 | <0.28 | >200 | <55 | <0.28 |
Average of three or more determinations with standard deviations shown.
Calculated efficiency using 0.5 μg of purified VV TK and TK1 in each assay.